Boston Partners
Boston Partners is a fund in New York with $88.41B assets under management.
Company profile
Website
Employees
Incorporated in
Location
Fiscal year end
Former names
Robeco Investment Management, Inc.
SEC CIK
IRS number
980202744
SEC advisor number
801-61786
FINRA CRD number
124982
AUM ?
$88.41B
(as of 21 Feb 20)
Accounts
1,769
(as of 21 Feb 20)
Employees
157
(59 investment advisory or research)
Address
Boston Partners
ONE BEACON STREET
30TH FLOOR
BOSTON
MA 02108
ONE BEACON STREET
30TH FLOOR
BOSTON
MA 02108
Phone
2129089500
Brochures
| Fund structure | AUM | Fund type | |
|---|---|---|---|
| Boston Partners Global Investors, Inc. | $88.41B | ||
| Alpha Blue Capital L.P. | $30.66M | Hedge Fund | |
| Boston Partners Long/short Equity, L.P. | $186.13M | Hedge Fund | |
| WPG Partners Opportunistic Value Fund, L.P. | $16.7M | Hedge Fund | |
| Boston Partners International Equity Fund | $40.29M | Other Private Fund | |
| Boston Partners Global Equity Fund | $145.48M | Other Private Fund | |
| Boston Partners Select Equity DST | $5.12M | Other Private Fund |
Fund data
Regulatory AUM / Assets Under Management
Number of accounts
Number of employees
| Top 50 of 639 long holdings End of quarter 31 Mar 20 |
Value |
#Shares |
|---|---|---|
| $1.15B | 6.28M | |
| $926.61M | 43.68M | |
| $855.56M | 9.51M | |
| $849.07M | 6.48M | |
| $810.51M | 24.84M | |
| $802.9M | 4.53M | |
| $677.35M | 801.2K | |
| $641.21M | 33.74M | |
| $637.54M | 8.21M | |
| $610.26M | 5.47M | |
| $582.33M | 2.57M | |
| $578.32M | 6.42M | |
| $570.94M | 10.63M | |
| $556.69M | 6.29M | |
| $547.5M | 4.05M | |
| $546.24M | 4.97M | |
| $536.78M | 5.69M | |
| $507.68M | 17.7M | |
| $495.85M | 21.11M | |
| $495.41M | 6.71M | |
| $494.79M | 6.43M | |
| $479.85M | 5.72M | |
| $478.31M | 19.74M | |
| $471.43M | 8.61M | |
| $456.55M | 9.45M | |
| $446.05M | 1.79M | |
| $443.98M | 14.4M | |
| $433.94M | 10.31M | |
| $418.72M | 2.18M | |
| $413.71M | 356.22K | |
| $413.3M | 4.99M | |
| $402.81M | 3.17M | |
| $391.7M | 11.4M | |
| $388.73M | 703.99K | |
|
Glaxosmithkline PLC
|
$388.6M | 10.26M |
| $378.22M | 4.69M | |
| $363.93M | 2.53M | |
| $359.89M | 5M | |
| $357.75M | 10.5M | |
| $357.59M | 9.22M | |
| $349.86M | 4.28M | |
| $347.43M | 42.34M | |
| $346.22M | 3.43M | |
| $339.28M | 2.15M | |
| $328.45M | 20.58M | |
| $320.75M | 7.63M | |
| $320.34M | 7.07M | |
| $319.62M | 5.61M | |
| $316.32M | 3.39M | |
| $310.25M | 3.38M |
Holdings list only includes long positions.
Only includes long positions.
Calendar
6 Jun 20
31 Dec 20
News
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings
Ownership
13F-HR
Quarterly holdings report by institutional manager
13 May 20
SC 13G/A
Change Healthcare / Boston Partners ownership change
8 May 20
SC 13G/A
Beneficial ownership report (amended)
11 Feb 20
SC 13G/A
Wyndham Destinations, Inc.
11 Feb 20
SC 13G/A
World Fuel Services Corp
11 Feb 20
SC 13G/A
White Mountains Insurance Group LTD
11 Feb 20
SC 13G/A
Wesco International Inc
11 Feb 20
SC 13G/A
Beneficial ownership report (amended)
11 Feb 20
SC 13G/A
SL Green Realty Corp
11 Feb 20
SC 13G/A
Beneficial ownership report (amended)
11 Feb 20